drugset / Trial / NCT06818968

A Study of the Effect of Multiple Doses of Diltiazem on the Plasma Levels of MK-6916 in Healthy Participants (MK-6916-005)

NCT06818968

Phase 1 Completed 37 enrolled Merck Sharp & Dohme LLC
NaSingle-groupOpen-labelBasic science

Summary

The goal of the study is to learn what happens to levels of MK-6916 in a healthy person's body over time. Researchers will compare what happens to MK-6916 in the body when it is given with or without another medicine called diltiazem.

Timeline

Start
2025-02-27
Primary completion
2025-08-08
Completion
2025-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule Oral
Subject MK-6916 Unknown Oral

Indications

No indication recorded.